Filtros de búsqueda

Lista de obras de Catherine Sermet

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

artículo científico publicado en 2017

Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: A time-series analysis for France 1998–2010 ⬇️

artículo científico publicado el 29 de julio de 2011

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?

artículo científico

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

artículo científico publicado en 2018

Changes in osteoarthritis management by general practitioners in the COX2-inhibitor era-concomitant gastroprotective therapy

artículo científico publicado en 2004

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

artículo científico publicado en 2010

Cost of obesity in France

artículo científico publicado en 2007

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

artículo científico publicado en 2013

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

artículo científico publicado en 2014

Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review

artículo científico

Entry time effects and follow-on drug competition

artículo científico publicado en 2014

Factors influencing report of common mental health problems among psychologically distressed adults

artículo científico publicado en 2013

Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population

artículo científico publicado en 2017

Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future

article

Increased prevalence of depression, smoking, heavy drinking and use of psycho-active drugs among unemployed men in France

artículo científico publicado en 2004

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future

artículo científico publicado en 2016

Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France

artículo científico publicado en 2013

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications

artículo científico publicado en 2014

No significant decrease in antibiotic use from 1992 to 2000, in the French community

artículo científico publicado en 2004

Ongoing pharmaceutical reforms in France: implications for key stakeholder groups

artículo científico publicado en 2010

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways

artículo científico publicado en 2016

Personalizing health care: feasibility and future implications

artículo científico publicado en 2013

Policies to enhance prescribing efficiency in europe: findings and future implications

artículo científico publicado en 2010

Results per pathology. A prototype based on the year 1998

artículo científico publicado el 23 de agosto de 2003

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers

artículo científico publicado en 2010

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

artículo científico publicado en 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda